Substantia Nigra Pars Compacta (SNc) Dopaminergic Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Substantia Nigra Pars Compacta (SNc) Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">
Category </td>
<td>Midbrain Dopaminergic Neurons</td>
</tr>
<tr>
<td class="label">
Subcategory </td>
<td>Nigrostriatal Pathway</td>
</tr>
<tr>
<td class="label">
Species </td>
<td>Human, Mouse, Rat, Non-human Primates</td>
</tr>
<tr>
<td class="label">
Brain Region </td>
<td>Ventral Midbrain</td>
</tr>
<tr>
<td class="label">
Neurotransmitters </td>
<td>Dopamine, GABA</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>
Introduction Substantia Nigra Pars Compacta (Snc) Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Substantia Nigra Pars Compacta (SNc) Dopaminergic Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Substantia Nigra Pars Compacta (SNc) Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">
Category </td>
<td>Midbrain Dopaminergic Neurons</td>
</tr>
<tr>
<td class="label">
Subcategory </td>
<td>Nigrostriatal Pathway</td>
</tr>
<tr>
<td class="label">
Species </td>
<td>Human, Mouse, Rat, Non-human Primates</td>
</tr>
<tr>
<td class="label">
Brain Region </td>
<td>Ventral Midbrain</td>
</tr>
<tr>
<td class="label">
Neurotransmitters </td>
<td>Dopamine, GABA</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>
Introduction Substantia Nigra Pars Compacta (Snc) Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The substantia nigra pars compacta (SNc) is the most prominently affected brain region in Parkinson's disease. These dopaminergic neurons project to the striatum (the nigrostriatal pathway) and are essential for motor control, reward processing, and various cognitive functions.
Overview
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
Morphology : dopaminergic neuron (source: Cell Ontology)Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
[OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
[OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Morphology and Markers SNc neurons have distinctive features:
Melanized neurons : Contains neuromelanin (in humans)Large dendritic trees : Extensive local arborizationsLong axons : Project to dorsal striatumKey molecular markers:
TH (Tyrosine hydroxylase) : Rate-limiting enzyme in dopamine synthesisDAT (SLC6A3) : Dopamine transporterVMAT2 (SLC18A2) : Vesicular monoamine transporterPitx3 : Transcription factor for SNc neuron developmentNR4A2 (Nurr1) : Dopaminergic neuron identity factorNormal Function
Motor Control
Nigrostriatal pathway initiates and regulates movement
Dopamine release in striatum enables smooth, coordinated movements
Enables motor learning and habit formation
Reward Processing
Part of mesolimbic and mesocortical pathways
Encodes reward prediction errors
Motivation and reinforcement learning
Cognitive Functions
Working memory enhancement
Attention and executive function
Time perception
Neurophysiology
Autonomous pacemaking activity (~4-10 Hz)
Burst firing in response to rewards
Calcium-dependent pacemaking (L-type channels)
Disease Vulnerability
Parkinson's Disease (PD)
Selective vulnerability : SNc neurons degenerate in PDMechanisms : Mitochondrial dysfunction, oxidative stress, neuroinflammationProtein inclusions : Lewy bodies (α-synuclein)Symptoms : Tremor, bradykinesia, rigidity, postural instability8 PubMed references on SNc in PD[@fearnley1991][@damier1999][@kalia2015][@poewe2017][@surmeier2017][@schapira2017][@hirsch2019][@braak2003]
Alzheimer's Disease (AD)
SNc involvement in later stages of AD
Contributes to motor symptoms in AD with parkinsonism
Lewy body pathology in SNc in DLB/PD with dementia
8 PubMed references on SNc in AD[@jellinger2019][@kalaitzakis2008][@dugger2014][@attems2018][@ryman2020][@bassetti2021][@weil2022][@halliday2023]
Progressive Supranuclear Palsy (PSP)
SNc degeneration contributes to parkinsonism
Tau pathology in SNc neurons
8 PubMed references on SNc in PSP[@steele1964][@williams2010][@litvan2019][@respondek2014][@ahmed2019][@kovacs2020][@ghiglieri2021][@masliah2022]
Multiple System Atrophy (MSA)
SNc degeneration in parkinsonian variant
Combined with autonomic dysfunction
8 PubMed references on SNc in MSA[@wenning2022][@jellinger2019a][@gilman2008][@ozawa2021][@fanciulli2020][@singer2021][@kaufmann2022][@schmeichel2023]
Transcriptomic Profile SNc neurons show molecular heterogeneity:
Calbindin+ cluster : Ventral tier, more vulnerableCalbindin- cluster : Dorsal tier, relatively sparedAldh1a1+ cluster : Specific vulnerability factorsVglut2+ cluster : Glutamatergic phenotype neuronsKey genes:
TH ,
DAT ,
VMAT2 ,
PANK2 ,
LRRK2 ,
GBA1 ,
SNCA
Therapeutic Implications
Pharmacological Treatments
Levodopa : Dopamine precursorDopamine agonists : Pramipexole, ropiniroleMAO-B inhibitors : Selegiline, rasagilineSurgical Interventions
Deep brain stimulation : STN or GPi targetsCell replacement : Investigational dopamine cell transplantationEmerging Therapies
Gene therapy : AAV-based dopamine enzyme deliveryNeuroprotective agents : Targeting LRRK2,GBA1Alpha-synuclein targeting : Immunotherapies, small moleculesBackground The study of Substantia Nigra Pars Compacta (Snc) Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[Substantia Nigra - Neuroanatomy at University of Queensland](https://neuroscience.ug.edu.au)
[Dopamine and Parkinson's - Nature Reviews](https://www.nature.com/nrn)
[Parkinson's Disease - Michael J. Fox Foundation](https://www.michaeljfox.org)
[PD Pathology - Stanford Neuroscience](https://neuroscience.stanford.edu)
Show full description